300158 振东制药
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.031-29.934-0.843-0.76938.143
总资产报酬率 ROA (%)0.024-23.803-0.691-0.61629.581
投入资产回报率 ROIC (%)0.030-28.856-0.807-0.72834.670

边际利润分析
销售毛利率 (%)49.09047.49050.37549.31459.667
营业利润率 (%)1.656-24.055-0.827-0.15961.282
息税前利润/营业总收入 (%)0.919-44.301-1.3030.12661.457
净利润/营业总收入 (%)0.133-44.863-1.320-1.52951.232

收益指标分析
经营活动净收益/利润总额(%)-68.02931.235401.7133,667.0272.700
价值变动净收益/利润总额(%)64.3787.412-119.491-1,250.83394.803
营业外收支净额/利润总额(%)-88.78145.65120.453-12.118-0.175

偿债能力分析
流动比率 (X)3.0262.5624.8644.0384.680
速动比率 (X)2.3451.9443.5603.1504.159
资产负债率 (%)21.81126.54116.76920.26620.201
带息债务/全部投入资本 (%)1.2802.0841.2112.8934.074
股东权益/带息债务 (%)7,575.8824,613.8667,972.6533,282.5432,314.544
股东权益/负债合计 (%)362.191279.601499.702395.756396.256
利息保障倍数 (X)22.2521,087.7644.9400.471218.054

营运能力分析
应收账款周转天数 (天)70.76069.33666.03076.49971.145
存货周转天数 (天)166.236227.454227.064191.597154.396